Amylyx Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 1.1M | 13.59 |
| 2025-06-30 | $7.4M | 1.2M | 6.41 |
| 2025-03-31 | $4.2M | 1.2M | 3.54 |
| 2024-12-31 | $4.8M | 1.3M | 3.78 |
| 2024-09-30 | $2.9M | 881k | 3.24 |
| 2024-06-30 | $1.2M | 622k | 1.90 |
| 2024-03-31 | $1.5M | 527k | 2.84 |
| 2023-12-31 | $3.8M | 257k | 14.72 |
| 2023-09-30 | $2.3M | 125k | 18.31 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management